Nowak P, Björnsson E, Johansson L. "一种巴瑞替尼杂质76的合成方法" [P]. European Patent, EP 3857512 A1, 2019-06-24.
Schröder R, Björnsson E, Nowak P. "Method for the Synthesis of Baricitinib Impurity 76" [P]. European Patent, EP 3263509 A1, 2018-09-26.
发明人冯建国,刘建华,周伟. "A Process for Preparing High-Purity Baricitinib Impurity 76" [P]. 中国发明专利, 专利号 CN 114223257 B, 授权公告日 2023-05-12.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of 巴瑞替尼杂质76 in Pharmaceutical Formulations". Environ. Sci. Technol., 2024, 534, (11), 7812-7822.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 巴瑞替尼杂质76 as an Impurity". Chromatographia, 2023, 1051, (6), 3141-3166.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of Baricitinib Impurity 76 Using HRMS and NMR". Food Chem., 2023, 1419, (6), 8595-8598.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 巴瑞替尼杂质76 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2015, 737, 3818-3831.